Get started
Author

Julie Jacobs

Observed names: J. Jacobs, Jacobs Julie, Jacobs, Julie
Institution: Argenx (Belgium)
ORCID: 0000-0003-2873-3364
Observed ORCID: 0000-0003-2873-3364
OpenAlex ID: A5017717631
The potential and controversy of targeting STAT family members in cancer
2019 · Yannick Verhoeven, Sam Tilborghs, et al. · Seminars in Cancer Biology · 418
PDF
The CD70-CD27 axis in oncology: the new kids on the block
2022 · Tal Flieswasser, Astrid Van den Eynde, et al. · Journal of Experimental & Clinical Cancer Research · 219
PDF
CD70: An emerging target in cancer immunotherapy
2015 · J. Jacobs, V. Deschoolmeester, et al. · Pharmacology & Therapeutics · 211
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
2019 · Jinthe Van Loenhout, Tal Flieswasser, et al. · Cancers · 123
PDF
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
2024 · Astrid Van den Eynde, Laura Gehrcken, et al. · Journal of Hematology & Oncology · 110
PDF
Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
2019 · Laure Sorber, Karen Zwaenepoel, et al. · Cancers · 100
PDF
Immune Checkpoint Modulation in Colorectal Cancer: What’s New and What to Expect
2015 · Julie Jacobs, Evelien Smits, et al. · Journal of Immunology Research · 84
PDF
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
2018 · Julie Jacobs, Vanessa Deschoolmeester, et al. · OncoImmunology · 73
PDF
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
2015 · Christophe Deben, An Wouters, et al. · Oncotarget · 73
PDF
CD 70 and PD ‐L1 in anaplastic thyroid cancer – promising targets for immunotherapy
2017 · Karen Zwaenepoel, Julie Jacobs, et al. · Histopathology · 70
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method
2019 · Tal Flieswasser, Valérie Camara-Clayette, et al. · Cancers · 67
PDF
APR-246 (PRIMA-1 MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines
2016 · Christophe Deben, Filip Lardon, et al. · Cancer Letters · 61
Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
2015 · Julie Jacobs, Karen Zwaenepoel, et al. · Oncotarget · 61
PDF
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
2018 · Christophe Deben, Vanessa Deschoolmeester, et al. · Cancers · 59
PDF
Clinically Relevant Chemotherapeutics Have the Ability to Induce Immunogenic Cell Death in Non-Small Cell Lung Cancer
2020 · Tal Flieswasser, Jinthe Van Loenhout, et al. · Cells · 57
PDF
Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status
2020 · Hasan Baysal, Ines De Pauw, et al. · British Journal of Cancer · 47
PDF
Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions
2019 · Laure Sorber, Karen Zwaenepoel, et al. · Molecular Diagnosis & Therapy · 46
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma
2021 · Nicolas Leupin, Pier Luigi Zinzani, et al. · Cancer · 39
RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review
2019 · Peter A. van Dam, Yannick Verhoeven, et al. · International Journal of Molecular Sciences · 34
PDF
Deep sequencing of the TP53 gene reveals a potential risk allele for non–small cell lung cancer and supports the negative prognostic value of TP53 variants
2017 · Christophe Deben, Jolien Van den Bossche, et al. · Tumor Biology · 32
PDF
Mass Spectrometry Imaging Reveals Neutrophil Defensins as Additional Biomarkers for Anti-PD-(L)1 Immunotherapy Response in NSCLC Patients
2020 · Eline Berghmans, Julie Jacobs, et al. · Cancers · 29
PDF
In vitro study of the Polo‐like kinase 1 inhibitor volasertib in non‐small‐cell lung cancer reveals a role for the tumor suppressor p53
2019 · Jolien Van den Bossche, Christophe Deben, et al. · Molecular Oncology · 27
PDF
Site-specific 68Ga-labeled nanobody for PET imaging of CD70 expression in preclinical tumor models
2023 · Jonatan Dewulf, Tal Flieswasser, et al. · EJNMMI Radiopharmacy and Chemistry · 25
PDF
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression
2019 · Vasiliki Siozopoulou, Elly Marcq, et al. · Cancer Immunology Immunotherapy · 22
A Multicenter Study to Assess EGFR Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting
2018 · Laure Sorber, Karen Zwaenepoel, et al. · Cancers · 21
PDF
Works count: 60
Citation count: 2,249
H-index: 23
I10-index: 33
Year
Topic
Type